Table 1.
Patient characteristics at the time of muscularity assessment (n= 40 patients)
| Variables | Values |
|---|---|
| Age, years, median (range) | 62 (41–80) |
| Sex, male, n (%) | 24 (60.0) |
| Weight, kg, median (range) | 76 (49–127) |
| Height, cm, median (range) | 172 (155–195) |
| BMI, kg/m2, median (range) | 25 (19.3–42.9) |
| Fat-free body mass, kg, median (range) | 48 (31–66) |
| BSA, m2, median (range) | 1.9 (1.47–2.46) |
| Preoperative laboratory tests, median (range) | |
| Bilirubin, µmol/l (normal < 20) | 11.8 (6.9–9.5) |
| ALT, U/l (normal < 50) | 26 (7–67) |
| AST, U/l (normal < 38) | 21 (7–52) |
| LDH, U/l (normal 120–250) | 367 (263–595) |
| Ggt, U/l (normal < 55) | 45 (13–258) |
| CRP (normal < 10) | 3 (1–88) |
| Creatinine, µmol/l (normal 60–115) | 87 (46–287) |
| Preoperative muscle status, cm2/m2, median (range) | |
| L3 muscle index in all patients | 46.4 (29.4–70.8) |
| L3 muscle index in men | 49.5 (35.5–70.8) |
| L3 muscle index in women | 38.4 (29.4–61.0) |
| Sarcopenic patients, n (%) | 27 (62.5) |
BMI, body mass index; BSA, body surface area; ALT, alanine aminotransferase; AST, aspartate aminotransferase; LDH, lactate dehydrogenase; Ggt, γ-glutamyl transferase; CRP, C-reactive protein.